The processed isoform of the translation termination factor eRF3 localizes to the nucleus to interact with the ARF tumor suppressor

•So far, eRF3 has been thought to function exclusively in the cytoplasm.•eRF3 is a nucleo-cutoplasmic shuttling protein.•eRF3 has a leptomycin-sensitive nuclear export signal (NES).•Removal of NES by proteolytic cleavage allows eRF3 to translocate to the nucleus.•The processed eRF3 (p-eRF3) interacts with a nuclear tumor suppressor ARF.

The eukaryotic releasing factor eRF3 is a multifunctional protein that plays pivotal roles in translation termination as well as the initiation of mRNA decay. eRF3 also functions in the regulation of apoptosis; eRF3 is cleaved at Ala73 by an as yet unidentified protease into processed isoform of eRF3 (p-eRF3), which interacts with the inhibitors of apoptosis proteins (IAPs). The binding of p-eRF3 with IAPs leads to the release of active caspases from IAPs, which promotes apoptosis. Although full-length eRF3 is localized exclusively in the cytoplasm, p-eRF3 localizes in the nucleus as well as the cytoplasm. We here focused on the role of p-eRF3 in the nucleus. We identified leptomycin-sensitive nuclear export signal (NES) at amino acid residues 61–71 immediately upstream of the cleavage site Ala73. Thus, the proteolytic cleavage of eRF3 into p-eRF3 leads to release an amino-terminal fragment containing NES to allow the relocalization of eRF3 into the nucleus. Consistent with this, p-eRF3 more strongly interacted with the nuclear ARF tumor suppressor than full-length eRF3. These results suggest that while p-eRF3 interacts with IAPs to promote apoptosis in the cytoplasm, p-eRF3 also has some roles in regulating cell death in the nucleus.

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide